跳至主要内容
临床试验/NCT05437276
NCT05437276已完成不适用

A Therapeutic Experience Program (TEP) Study Assessing Adherence to On-Label PoNS® Therapy for Improvement of Gait in People with Multiple Sclerosis (MS) in a Real-World Clinical Setting

Helius Medical Inc5 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2022年7月1日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
43
试验地点
5
主要终点
Measure subjects' adherence to PoNS therapy (device + physical therapy)

研究概览

简要总结

PoNS therapy is a rehabilitation program that uses the PoNS device in conjunction with individualized physical exercise. This is an outcome research open label observational interventional multi-center study investigating the relationship between subject's adherence to PoNS therapy and therapeutic outcomes.

详细描述

Study participants will undergo fourteen weeks of on-label PoNS therapy and, specifically, two weeks in-clinic PoNS therapy directly supervised by a physical therapist who has been trained on PoNS therapy by Helius Medical and certified as a clinic PoNS trainer (Phase 1) followed by 12 weeks of at-home unsupervised PoNS therapy Once weekly in-clinic PoNS therapy session (Phase 2). Subjects will be then asked to return to the clinic six month after the end of the study Phase 2 to assess maintenance of PoNS therapy effects.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women ≥ 22 years of age with a diagnosis of MS.
  • EDSS scores < 6.5 at screening; a demonstrated gait deficit.
  • Can walk at least 10 meters with or without the use of walking aids.
  • Participants must be stable without relapse for at least 60 days and agree to PoNS therapy regimen.

排除标准

  • Other neurological, visual, or orthopedic problems that significantly interfere with balance or gait.
  • Subjects who are currently attending physical rehabilitation and are unwilling to switch to PoNS-specific physical therapy regimen.
  • Subjects who are already functional community ambulators (gait speed>120cm/s43).
  • Subjects will also be excluded as per the Helius Medical PoNS device indication for usage ("electrical stimulation should not be used: if there is an active or suspected malignant tumor; in areas of recent bleeding or open wounds; in areas that lack normal sensation; in women who are pregnant, or in people with sensitivity to nickel, gold or copper").

结局指标

主要结局

Measure subjects' adherence to PoNS therapy (device + physical therapy)

时间窗: 14 weeks

Subjects' adherence to at-home PoNS therapy (device + physical therapy) over 12 weeks following 2 weeks of supervised PoNS therapy at a physical therapy clinic and the relationship between subject's therapy adherence behavior and therapeutic functional outcomes as measured by the Dynamic Gait Index (DGI).

次要结局

  • 3) Association between likelihood of second course of therapy and magnitudes of improvement with adherence during the initial therapy(14 weeks)
  • 1) Clinical improvement and its relationship to adherence over the 14-week course of PoNS therapy by evaluating(14 weeks)
  • Clinical improvement among subjects receiving a second course of PoNS therapy as measured by:(14 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验